Stock screener

RCUS

Conviction 100HealthcareScan · Thu, Jun 25, 2026
RCUS$30.24+5.00%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 1.94M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Arcus Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.arcusbio.com
Price30.24
Change+5.00%
Gap-0.66%
Rel volume4.37×
Avg volume1.71M
Avg $ vol44.54M
SMA 2024.92
SMA 5024.73
SMA 20021.29
Price vs 50+22.27%
Price vs 200+42.03%
MA stackbullish
50/200 cross
Supertrendup · 24.88
RSI (14)73
MACD hist0.70
MACD crossbull · 4d
Stoch %K / %D88 / 91
ADX (14)19
+DI / −DI35 / 10
RSI divergence
MACD divergenceBullish
ATR %+5.29%
ADR %6.32%
52w high30.24
52w low7.95
From 52w high+0.00%
Above 52w low+280.38%
New 52w highYes
SqueezeOff
Bollinger width32.89%
%B1.15
Donchian pos87.96%
Donchian high31.39
Donchian low21.84
AVWAP (52w high)30.01
vs AVWAP high+0.76%
AVWAP (52w low)20.24
vs AVWAP low+49.43%
OBV trendUp
Chaikin MF (20)0.19
Today vs 20d4.37×
Avg vol (14d)1.94M
Avg vol (20d)1.71M
Avg $ vol (20d)44.54M
Market cap3.8B
RS 3m (vs SPY)+29.97%
RS 6m (vs SPY)+23.29%
RS line new highYes
Trend template8/8
Technical rank91.8
1 week+25.37%
1 month+25.32%
3 months+40.91%
6 months+30.23%
1 year+245.60%
YTD+29.84%
P/E-10.77
P/B7.26
P/S115.25
P/FCF-7.86
EPS-3.29
Div yield
ROE-67.37%
ROA-35.41%
Debt/Eq0.19
Current4.04
EV/EBITDA
Gross margin
Net margin
Rev growth-35.29%
EPS growth-24.73%
Price target36.75
Target upside21.53%
Analyst ratingBuy
Institutional101.20%
Ent. value3.7B
Revenue7M
Net income-128M
Gross profit
Free cash flow-484M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out125.77M
Employees601
ListedThu, Mar 15, 2018
Free float88.69M
Float %70.8%
Short interest11.71M
Days to cover12.6d
Short volume55.5%
Squeeze score77 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$1.01 · 4 est
Last EPS vs est−$1.02 vs −$0.92
Last surprise-10.9% miss
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank91.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance26.43
Support22.23
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RCUS

All disclosures →
No recent disclosed trades by Congress in RCUS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RCUS · 6 buys · 4 sells

InsiderSideShares
Jaen Juan C.
President · Common Stock · 2026-06-24
Sell6.43K
Jaen Juan C.
President · Common Stock · 2026-06-23
Sell1.7K
Jaen Juan C.
President · Common Stock · 2026-06-23
Sell14.07K
Jaen Juan C.
President · Common Stock · 2026-06-22
Sell9.24K
FALBERG KATHRYN E
Director · Stock Option (Right to Buy) · 2026-06-11
Grant16.9K
KANEKO YASUNORI
Director · Common Stock · 2026-06-11
Grant5.7K
KANEKO YASUNORI
Director · Stock Option (Right to Buy) · 2026-06-11
Grant16.9K
Machado Patrick
Director · Common Stock · 2026-06-11
Grant5.7K
Machado Patrick
Director · Stock Option (Right to Buy) · 2026-06-11
Grant16.9K
Lacey David L.
Director · Stock Option (Right to Buy) · 2026-06-11
Grant16.9K

SEC filings

EDGAR filings in RCUS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.